1,301 research outputs found
Home enteral nutrition in Spain: NADYA registry 2010
Objetivos: Describir los resultados del registro de
nutrición enteral domiciliaria (NED) del grupo NADYASENPE
del año 2010.
Material y métodos: Se recopilaron los datos introducidos
en el registro desde el 1 de enero al 31 de diciembre de
2010.
Resultados: Se registraron 6.591 pacientes (51% varones)
con 6.688 episodios de NED, procedentes de 32 hospitales.
La edad media en los menores de 14 años (4%) fue
de 1 ± 2 años (m ± DS) y de 69,9 ± 17,8 en los mayores de
14 años. El 76% de los pacientes recibieron la NED por un
tiempo superior a 2 años. La patología más prevalente fue
la neurológica 42%, seguida de la neoplasia 28% (en su
mayoría cáncer de cabeza y cuello 18%). La información
referente a la vía de acceso sólo se recogió en 626 casos
(9,4%), el 51% de los pacientes utilizaron sonda nasogástrica,
27% gastrostomías, 10% vía oral y 3% yeyunostomías.
Sólo 251 episodios finalizaron a lo largo del año,
siendo el motivo más frecuente el fallecimiento del
paciente en el 57% de los casos y el paso a la alimentación
oral en el 14%. El 29% de los pacientes presentaban una
actividad limitada y el 39% estaba confinado en cama/
sillón. El 68% de los adultos requerían ayuda total o parcial.
El suministro del producto se realizó desde el hospital
o la farmacia de referencia en el 63% y 34%, respectivamente.
El suministro del material fungible se realizó
desde el hospital o atención primaria en el 83% y 16%,
respectivamente.
Conclusiones: Los resultados obtenidos en el registro
de NED del año 2010 muestran características muy similares
a las recogidas en los años previos en cuanto al
número y características de los pacientes registrados.
Seguimos encontrando problemas en la recogida de datos
relativos a la vía de acceso y finalización de los episodiosObjective: To describe the results of the home enteral
nutrition (HEN) registry of the NADYA-SENPE group in
2010.
Material and methods: We retrieved the data of the
patients recorded from January 1st to December 31st
2010.
Results: We registered 6,591 patients (51% males) with
6,688 episodes of HEN, from 32 hospitals. Mean age in
those younger than 14 yr (4%) was 1 ± 2 yrs (m ± SD) and
69,9 ± 17,8 yrs in those older than 14 yr. The length of
HEN was longer than 2 yrs in 76% of the patients. The
most frequent underlying disease was neurological disorders
42%, followed by cancer 28% (mostly head and neck
cancer 18%). We had information related to the enteral
access route in only 626 cases (9,4%), 51% of them used
nasogastric tubes, 27% gastrostomies, 10% oral route
and 3% jejunostomies. Only 251 episodes were closed
during the year, mostly due to patient death 57% and
progress to oral diet 14%. The activity level was limited in
29% of the patients and 39% of them were bed- or chairridden.
Total or partial help was needed by 68% of the
patients. The hospitals and the private pharmacies delivered
the enteral formula in 63% and 34% of the cases,
respectively. The hospitals and the primary care centres
delivered the disposables in 83% and16% of the cases,
respectively.
Conclusions: The results of the 2010 HEN registry are
similar to those published in previous years regarding the
number and characteristics of the patients. We continue
finding problems in the entrance of data referred to the
enteral access route and the closing of the episode
The Astropy Project: Building an Open-science Project and Status of the v2.0 Core Package
The Astropy Project supports and fosters the development of open-source and openly developed Python packages that provide commonly needed functionality to the astronomical community. A key element of the Astropy Project is the core package astropy, which serves as the foundation for more specialized projects and packages. In this article, we provide an overview of the organization of the Astropy project and summarize key features in the core package, as of the recent major release, version 2.0. We then describe the project infrastructure designed to facilitate and support development for a broader ecosystem of interoperable packages. We conclude with a future outlook of planned new features and directions for the broader Astropy Project
Measurement of the mass and lifetime of the baryon
A proton-proton collision data sample, corresponding to an integrated
luminosity of 3 fb collected by LHCb at and 8 TeV, is used
to reconstruct , decays. Using the , decay mode for calibration, the lifetime ratio and absolute
lifetime of the baryon are measured to be \begin{align*}
\frac{\tau_{\Omega_b^-}}{\tau_{\Xi_b^-}} &= 1.11\pm0.16\pm0.03, \\
\tau_{\Omega_b^-} &= 1.78\pm0.26\pm0.05\pm0.06~{\rm ps}, \end{align*} where the
uncertainties are statistical, systematic and from the calibration mode (for
only). A measurement is also made of the mass difference,
, and the corresponding mass, which
yields \begin{align*} m_{\Omega_b^-}-m_{\Xi_b^-} &= 247.4\pm3.2\pm0.5~{\rm
MeV}/c^2, \\ m_{\Omega_b^-} &= 6045.1\pm3.2\pm 0.5\pm0.6~{\rm MeV}/c^2.
\end{align*} These results are consistent with previous measurements.Comment: 11 pages, 5 figures, All figures and tables, along with any
supplementary material and additional information, are available at
https://lhcbproject.web.cern.ch/lhcbproject/Publications/LHCbProjectPublic/LHCb-PAPER-2016-008.htm
Observation of two new baryon resonances
Two structures are observed close to the kinematic threshold in the mass spectrum in a sample of proton-proton collision data, corresponding
to an integrated luminosity of 3.0 fb recorded by the LHCb experiment.
In the quark model, two baryonic resonances with quark content are
expected in this mass region: the spin-parity and
states, denoted and .
Interpreting the structures as these resonances, we measure the mass
differences and the width of the heavier state to be
MeV,
MeV,
MeV, where the first and second
uncertainties are statistical and systematic, respectively. The width of the
lighter state is consistent with zero, and we place an upper limit of
MeV at 95% confidence level. Relative
production rates of these states are also reported.Comment: 17 pages, 2 figure
Search for hidden-sector bosons in decays
A search is presented for hidden-sector bosons, , produced in the decay
, with and
. The search is performed using -collision data
corresponding to 3.0 fb collected with the LHCb detector. No significant
signal is observed in the accessible mass range
MeV, and upper limits are placed on the branching fraction product
as
a function of the mass and lifetime of the boson. These limits are of
the order of for lifetimes less than 100 ps over most of the
range, and place the most stringent constraints to date on many
theories that predict the existence of additional low-mass bosons.Comment: All figures and tables, along with supplementary material, are
available at
https://lhcbproject.web.cern.ch/lhcbproject/Publications/LHCbProjectPublic/LHCb-PAPER-2015-036.htm
Impact of biological agents on postsurgical complications in inflammatory bowel disease: A multicentre study of Geteccu
Background: The impact of biologics on the risk of postoperative complications (PC) in inflammatory bowel disease (IBD) is still an ongoing debate. This lack of evidence is more relevant for ustekinumab and vedolizumab. Aims: To evaluate the impact of biologics on the risk of PC. Methods: A retrospective study was performed in 37 centres. Patients treated with biologics within 12 weeks before surgery were considered “exposed”. The impact of the exposure on the risk of 30-day PC and the risk of infections was assessed by logistic regression and propensity score-matched analysis. Results: A total of 1535 surgeries were performed on 1370 patients. Of them, 711 surgeries were conducted in the exposed cohort (584 anti-TNF, 58 vedolizumab and 69 ustekinumab). In the multivariate analysis, male gender (OR: 1.5; 95% CI: 1.2–2.0), urgent surgery (OR: 1.6; 95% CI: 1.2–2.2), laparotomy approach (OR: 1.5; 95% CI: 1.1–1.9) and severe anaemia (OR: 1.8; 95% CI: 1.3–2.6) had higher risk of PC, while academic hospitals had significantly lower risk. Exposure to biologics (either anti-TNF, vedolizumab or ustekinumab) did not increase the risk of PC (OR: 1.2; 95% CI: 0.97–1.58), although it could be a risk factor for postoperative infections (OR 1.5; 95% CI: 1.03–2.27). Conclusions: Preoperative administration of biologics does not seem to be a risk factor for overall PC, although it may be so for postoperative infections
Measurement of the lifetime
Using a data set corresponding to an integrated luminosity of ,
collected by the LHCb experiment in collisions at centre-of-mass energies
of 7 and 8 TeV, the effective lifetime in the
decay mode, , is measured to be ps. Assuming
conservation, corresponds to the lifetime of the light
mass eigenstate. This is the first measurement of the effective
lifetime in this decay mode.Comment: All figures and tables, along with any supplementary material and
additional information, are available at
https://lhcbproject.web.cern.ch/lhcbproject/Publications/LHCbProjectPublic/LHCb-PAPER-2016-017.htm
Constraints on the unitarity triangle angle from Dalitz plot analysis of decays
The first study is presented of CP violation with an amplitude analysis of
the Dalitz plot of decays, with , and . The analysis is based on a data sample corresponding to
of collisions collected with the LHCb detector. No
significant CP violation effect is seen, and constraints are placed on the
angle of the unitarity triangle formed from elements of the
Cabibbo-Kobayashi-Maskawa quark mixing matrix. Hadronic parameters associated
with the decay are determined for the first time. These
measurements can be used to improve the sensitivity to of existing and
future studies of the decay.Comment: All figures and tables, along with any supplementary material and
additional information, are available at
https://lhcbproject.web.cern.ch/lhcbproject/Publications/LHCbProjectPublic/LHCb-PAPER-2015-059.html;
updated to correct figure 9 (numerical results unchanged
Search for the rare decays and
A search for the rare decay of a or meson into the final
state is performed, using data collected by the LHCb experiment
in collisions at and TeV, corresponding to an integrated
luminosity of 3 fb. The observed number of signal candidates is
consistent with a background-only hypothesis. Branching fraction values larger
than for the decay mode are
excluded at 90% confidence level. For the decay
mode, branching fraction values larger than are excluded at
90% confidence level, this is the first branching fraction limit for this
decay.Comment: All figures and tables, along with any supplementary material and
additional information, are available at
https://lhcbproject.web.cern.ch/lhcbproject/Publications/LHCbProjectPublic/LHCb-PAPER-2015-044.htm
A model-independent confirmation of the state
The decay is analyzed using of
collision data collected with the LHCb detector. A model-independent
description of the mass spectrum is obtained, using as input the
mass spectrum and angular distribution derived directly from data,
without requiring a theoretical description of resonance shapes or their
interference. The hypothesis that the mass spectrum can be
described in terms of reflections alone is rejected with more than
8 significance. This provides confirmation, in a model-independent way,
of the need for an additional resonant component in the mass region of the
exotic state.Comment: All figures and tables, along with any supplementary material and
additional information, are available at
https://lhcbproject.web.cern.ch/lhcbproject/Publications/LHCbProjectPublic/LHCb-PAPER-2015-038.htm
- …